Sakar Healthcare Limited

NSE:SAKAR.NS

322.8 (INR) • At close November 5, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12016 Q42015 Q42015 Q32015 Q22015 Q12014 Q4
Revenue 427.781411.477430.588372.255340.786389.888406.51334.653307.088285.339365.874297.404316.41302.579216.814267.934261.168201.476182.603222.638260.686163.875194.281216.682162.984108.546230.011218.666110.25196.79796.79782.273
Cost of Revenue 334.719325.034349.788296.743168.645211.707224.728180.58170.674159.484206.442170.917196.457174.32791.579177.283139.201106.87191.464124.538140.55681.42698.583117.67487.15453.532110.437114.89367.49942.3442.3446.282
Gross Profit 93.06286.44380.875.512172.141178.181181.782154.073136.414125.855159.432126.487119.953128.252125.23690.651121.96794.60591.1498.1120.1382.44995.69999.00875.8355.014119.574103.77342.75354.45854.45835.991
Gross Profit Ratio 0.2180.210.1880.2030.5050.4570.4470.460.4440.4410.4360.4250.3790.4240.5780.3380.4670.470.4990.4410.4610.5030.4930.4570.4650.5070.520.4750.3880.5630.5630.437
Reseach & Development Expenses 0000006.0580000000000016.33200012.48000000000
General & Administrative Expenses 00000048.89800017.74700026.21600035.40900028.014000013.00113.00210.94410.94413.214
Selling & Marketing Expenses 0000001.670001.3630000.1760001.2870001.49600000.7240.7230.1240.1240.099
SG&A 29.2430.02919.76929.86731.35853.64950.56818.81315.40614.2419.1126.39715.83931.20726.39235.45534.59930.56336.69630.03334.02421.82629.5127.20620.21914.091013.72513.72511.06711.06713.313
Other Expenses 04.59802.3096.57715.20818.17818.5395.9524.079-12.3092.6837.4792.709-1.882.662.6232.3321.4542.1964.3323.361-0.0681.2391.233.20878.56868.8320000
Operating Expenses 29.2430.02919.76929.867120.757133.11139.489107.03488.06181.97891.32986.14565.80885.219102.62762.83463.16958.29464.13965.19179.93457.86262.9564.95847.04641.20478.56868.83236.63832.08232.08232.133
Operating Income 63.82256.41461.03145.64557.9645.07160.36965.57854.30543.87759.06240.34254.14543.03322.60927.81758.79836.31127.00932.90940.19624.58732.74934.0528.78413.8127.32920.6236.43522.53522.5354.471
Operating Income Ratio 0.1490.1370.1420.1230.170.1160.1490.1960.1770.1540.1610.1360.1710.1420.1040.1040.2250.180.1480.1480.1540.150.1690.1570.1770.1270.1190.0940.0580.2330.2330.054
Total Other Income Expenses Net -12.711-9.383-13.081-15.613-16.451-5.565-21.489-19.446-9.926-4.5072.062-6.75-0.41-2.162-0.327-5.321-3.508-4.0393.735-3.694-0.822-1.651-0.77-4.856-3.057-2.441-13.682-14.318-7.108-7.471-7.471-3.202
Income Before Tax 51.11147.03147.9530.03241.50939.50638.8846.13244.37939.3761.12333.59253.73540.87122.28222.49655.2932.27230.74429.21539.37422.93631.97929.19425.72711.36927.32420.623-0.67315.06515.0651.269
Income Before Tax Ratio 0.1190.1140.1110.0810.1220.1010.0960.1380.1450.1380.1670.1130.170.1350.1030.0840.2120.160.1680.1310.1510.140.1650.1350.1580.1050.1190.094-0.0060.1560.1560.015
Income Tax Expense 3.14822.91116.7439.2895.15311.103-0.3456.00524.9310.585-28.35832.46229.0914.3284.9234.5019.6726.4082.1277.1199.9826.81311.5399.6423.223.051443.5876.3376.3372.519
Net Income 47.96324.1231.20720.74336.35628.40339.22540.12719.44928.78589.4821.1324.64436.54317.35917.99545.61825.86428.61722.09629.39216.12320.43919.55222.5078.31823.32416.6232.9148.7288.7283.788
Net Income Ratio 0.1120.0590.0720.0560.1070.0730.0960.120.0630.1010.2450.0040.0780.1210.080.0670.1750.1280.1570.0990.1130.0980.1050.090.1380.0770.1010.0760.0260.090.090.046
EPS 2.211.111.430.951.681.461.842.161.011.685.070.071.442.151.161.23.041.721.921.481.961.081.671.61.840.682.132.080.361.091.090.47
EPS Diluted 2.161.091.430.951.681.461.842.161.011.654.930.071.442.151.161.23.041.721.921.481.961.081.671.61.840.682.132.080.361.091.090.47
EBITDA 118.741106.989109.68690.092100.175105.46695.913106.53991.96983.64774.22769.19378.3867.54473.28841.24472.59249.13555.0148.36565.17445.62745.5154.92244.55429.45160.74449.06513.49729.14129.14110.267
EBITDA Ratio 0.2780.260.2550.2420.2940.2710.2360.3180.2990.2930.2030.2330.2480.2230.3380.1540.2780.2440.3010.2170.250.2780.2340.2530.2730.2710.2640.2240.1220.3010.3010.125